Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection

Adrienne G Randolph1,2, Wai-Ki Yip3, Emma Kaitlynn Allen4

  • 1Department of Anesthesia, Perioperative and Pain Medicine, Boston Children's Hospital.

Abstract

Insights

The IFITM3 rs12252_C variant did not impact pediatric influenza infection risk or severity. This study found no association between this genetic marker and critical illness in children with influenza.

Area of Science:

  • Virology
  • Genetics
  • Pediatrics

Background:

  • Interferon-induced transmembrane protein 3 (IFITM3) is known to restrict influenza virus fusion.
  • A specific IFITM3 variant, rs12252_C, has been linked to influenza severity in adults.
  • The role of IFITM3 in pediatric influenza has not been previously investigated.

Purpose of the Study:

  • To evaluate the association of the IFITM3 rs12252 genetic variant with influenza infection and severity in children.
  • To determine if rs12252 acts as a splice site influencing IFITM3 expression in pediatric influenza.

Main Methods:

  • The Pediatric Influenza (PICFLU) study enrolled children with suspected influenza.
  • IFITM3 rs12252 was genotyped in pediatric patients and analyzed for association with infection and critical illness.
  • Splice site analysis was performed using patient RNA to investigate the functional impact of rs12252_C.

Main Results:

  • The IFITM3 rs12252 variant was not associated with influenza infection susceptibility in population or family-based analyses.
  • No association was found between rs12252 genotype and critical illness severity in children with influenza.
  • The study did not identify the Δ21 IFITM3 isoform or confirm rs12252 as a functional splice site.

Conclusions:

  • The IFITM3 rs12252 genetic variant is not associated with susceptibility to or severity of influenza-related critical illness in children.
  • The findings do not support rs12252 acting as a splice site in the context of pediatric influenza.

Related Concept Videos